The costs of treating breast cancer in the US: a synthesis of published evidence.
about
Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007.Cost-effectiveness of early detection of breast cancer in Catalonia (Spain).Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modalityThe out of pocket cost of breast cancer survivors: a review.Investigation of adverse-event-related costs for patients with metastatic breast cancer in a real-world settingHealth system costs for stage-specific breast cancer: a population-based approach.Out of pocket cost comparison between Caucasian and minority breast cancer survivors in the Breast Cancer Education Intervention (BCEI)Pharmacoeconomic considerations in the treatment of breast cancer.Patterns of resource utilization and cost for postmenopausal women with hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer in EuropeTherapy choices and quality of life in young breast cancer survivors: a short-term follow-upComparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service.Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States.Academic-Community Partnership to Develop a Patient-Centered Breast Cancer Risk Reduction Program for Latina Primary Care PatientsAcute skin toxicity-related, out-of-pocket expenses in patients with breast cancer treated with external beam radiotherapy: a descriptive, exploratory studyThe need for holistic cancer care framework: breast cancer care as an exampleRelevance of health economics in breast cancer treatment: integration of economics in the management of breast cancer at the clinic levelThe global impact of non-communicable diseases on healthcare spending and national income: a systematic review.Aligning cost assessment with community-based participatory research: the Kin KeeperSM intervention.Treatment Costs of Breast Cancer Among Younger Women Aged 19-44 Years Enrolled in Medicaid.Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway.Incidence-based cost-of-illness model for metastatic breast cancer in the United States.Differences in Medicare Expenditures Between Appalachian and Nationally Representative Cohorts of Elderly Women With Breast Cancer: An Application of Decomposition Technique.Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.The Influence of Social Determinants on Late Stage Breast Cancer for Women in Mississippi.Equity in Ghanaian breast cancer treatment outcomes-a modeling study in Komfo Anokye Teaching Hospital.Oncoplastic approach in the conservative treatment of breast cancer: analysis of costs.The association of chemotherapy versus hormonal therapy and health outcomes among patients with hormone receptor-positive, HER2-negative metastatic breast cancer: experience from the patient perspective.Red flags on pinkwashed drinks: contradictions and dangers in marketing alcohol to prevent cancer.Rising global burden of breast cancer: the case of sub-Saharan Africa (with emphasis on Nigeria) and implications for regional development: a review.
P2860
Q33577145-DAD92B64-03F5-4712-84CD-1C1FAEC9DFB8Q33909250-FD6D6011-A6E2-4AC6-82CA-B603A5D67FE7Q33933721-2E5C883C-9236-40C1-B79E-33A5D10E0ADCQ34069038-EED70C16-19CD-4381-AFD8-6F9686C63F0DQ34127931-5207E69E-A6FB-4409-AE77-C6B9FE2ECEEEQ34637835-1E2AB7BF-CE06-4216-9684-9B948908F8CFQ34928030-EBE60C2E-EA5E-4048-AE7D-5A129F249798Q35205385-E57F70B3-DE5A-45DD-B092-7F1004DD3BCAQ35820168-708B6F95-4012-49FB-A559-2A5C308ECA29Q35854949-AED326C9-17EA-4ADF-AD10-DB4CAA867041Q36771588-F6D17D38-6A6D-4CBE-BF78-AFB9DAC59457Q36849164-1E81F3A0-6170-48EF-9D7E-238C87076D16Q36992450-69AF0D81-4E70-42AB-A2F8-426B2576BB3AQ37064165-EF34D204-C4CA-4022-90B7-B0A7B0A8CA4CQ37160516-0E9FF363-209B-45D2-9D9E-6F87A2F0FD25Q37677710-6B5131A3-401A-4CCC-9E20-0A41A3DA7A2AQ38321172-5F3B8738-9BD3-48CC-A306-3300CBAB3416Q39098353-3BC91D41-62EC-4207-AA28-0A5AC559B2FAQ40098790-ED67A042-177C-48B9-AF0C-F38615E4546BQ40664161-91CD2552-172B-4192-AB6C-A9E09AF82389Q44244967-A47F5EC1-B282-49AC-85A3-4F6087A464ACQ45058524-77CD2E61-D13C-47D3-98C4-36D9D7343A12Q45072381-652B41AB-3B36-46E2-BF03-A12757B3F210Q46160648-32EF98A5-EB26-4E26-9431-558F96C4EF70Q46948884-4BF69035-295B-49CF-9FB0-17AF942E5025Q47663236-16AEFEFC-AB76-4EF9-A7FF-2D6596F993FAQ48068021-89E19DE4-2CCD-495A-87F0-ECEE7DC3A1E2Q50437426-46FCA240-7912-49AB-B651-754C0118D04DQ52642389-A46A44ED-7371-4A66-BFB3-259AE94801A4
P2860
The costs of treating breast cancer in the US: a synthesis of published evidence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The costs of treating breast cancer in the US: a synthesis of published evidence.
@en
The costs of treating breast cancer in the US: a synthesis of published evidence.
@nl
type
label
The costs of treating breast cancer in the US: a synthesis of published evidence.
@en
The costs of treating breast cancer in the US: a synthesis of published evidence.
@nl
prefLabel
The costs of treating breast cancer in the US: a synthesis of published evidence.
@en
The costs of treating breast cancer in the US: a synthesis of published evidence.
@nl
P1433
P1476
The costs of treating breast cancer in the US: a synthesis of published evidence.
@en
P2093
Jonathan D Campbell
Scott D Ramsey
P304
P356
10.2165/00019053-200927030-00003
P577
2009-01-01T00:00:00Z
P6179
1027336997